Aspen Pharmacare Holdings Ltd APN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ZAC15,767.00
- Day Range
- ZAC15,808.00–16,131.00
- 52-Week Range
- ZAC9,070.00–16,621.00
- Bid/Ask
- ZAC15,550.00 / ZAC16,191.00
- Shares Outstanding
- 432.92M
- Market Cap
- ZAC6.93T
- Volume/Avg
- 1M / 2M
Key Statistics
- Price/Earnings (Normalized)
- 28.55
- Price/Sales
- 1.83
- Dividend Yield (Trailing)
- 1.33%
- Dividend Yield (Forward)
- 1.46%
- Dividend Payment Schedule
- Oct
- Total Yield
- 1.34%
Company Profile
Aspen Pharmacare Holdings Ltd is a multinational pharmaceutical company. The group focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets. The business segments of the group are split between the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals business segments are: Injectables, Over-the-counter, and Prescription. The Manufacturing business segments are: Active Pharmaceutical Ingredients, Finished Dose Form, and Heparin. Its geographic regions are Africa Middle East, Europe CIS, Australasia, Asia, and America.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 9,557
- Website
- https://www.aspenpharma.com
Valuation
|
Metric
|
APN
|
|---|---|
Price/Earnings (Normalized) | 28.55 |
Price/Book Value | 0.87 |
Price/Sales | 1.83 |
Price/Cash Flow | 10.73 |
Price/Earnings
APN
Financial Strength
|
Metric
|
APN
|
|---|---|
Quick Ratio | 1.03 |
Current Ratio | 3.64 |
Interest Coverage | 0.17 |
Quick Ratio
APN
Profitability
|
Metric
|
APN
|
|---|---|
Return on Assets (Normalized) | 3.10% |
Return on Equity (Normalized) | 4.94% |
Return on Invested Capital (Normalized) | 4.35% |
Return on Assets
APN
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|%TQ%?f%Z | LOCK|cnv<k | $66B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|jKlGV@H | LOCK|GKJmd | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|Y#@Z!ZD | LOCK|M! | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|d@nV!kdy | LOCK|NkD | $29B | |||
| Viatris Inc
VTRS
| LOCK|Qt<Gkb@ | LOCK|b$ | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|gjG | LOCK|?j | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|WL%F<?$ | LOCK|^H | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|s@rJsf | LOCK|MP | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|ddwjsL | LOCK|#@Yw | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|R^#r>N | LOCK|&^! | $2B |
United States